These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 38923593
1. The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1. Dance B, Dardare A, Fleming J, Siow SF, Schlub TE, Crawford H, Saunderson RB, Wong C, Berman Y. J Dermatol; 2024 Aug; 51(8):1050-1059. PubMed ID: 38923593 [Abstract] [Full Text] [Related]
2. Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1. Lin MJ, Yao H, Vera K, Patel E, Johnson M, Caroline P, Ramos J, Mehta J, Hu X, Blakeley JO, Romo CG, Sarin KY. JAMA Dermatol; 2024 Oct 01; 160(10):1091-1098. PubMed ID: 39196570 [Abstract] [Full Text] [Related]
4. Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement. Bottesi G, Spoto A, Trevisson E, Zuccarello D, Vidotto G, Cassina M, Clementi M. Br J Dermatol; 2020 Jun 01; 182(6):1449-1457. PubMed ID: 31329288 [Abstract] [Full Text] [Related]
6. Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1. Varni JW, Nutakki K, Swigonski NL. Am J Med Genet A; 2019 Aug 01; 179(8):1476-1482. PubMed ID: 31081992 [Abstract] [Full Text] [Related]
8. Development and preliminary evaluation of the Neurofibromatosis Type 1 Adult Quality of Life (NF1-AdQoL) questionnaire. Crawford H, North K, Wilson MJ, Berman Y, McKelvey-Martin V, Morrison PJ, Fleming J, Barton B. Clin Exp Dermatol; 2022 Feb 01; 47(2):271-281. PubMed ID: 34342021 [Abstract] [Full Text] [Related]
11. Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American cases. Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P. Am J Med Genet A; 2006 Sep 15; 140(18):1893-8. PubMed ID: 16906549 [Abstract] [Full Text] [Related]
16. Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1. Cieza Rivera AM, Lobato Fuertes C, Fernández-Villa T, Martín Sánchez V, Atallah I. Orphanet J Rare Dis; 2024 Feb 24; 19(1):85. PubMed ID: 38402381 [Abstract] [Full Text] [Related]
20. The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin. Rice FL, Houk G, Wymer JP, Gosline SJC, Guinney J, Wu J, Ratner N, Jankowski MP, La Rosa S, Dockum M, Storey JR, Carroll SL, Albrecht PJ, Riccardi VM. PLoS One; 2019 Jul 30; 14(5):e0216527. PubMed ID: 31107888 [Abstract] [Full Text] [Related] Page: [Next] [New Search]